TABLE 2.
Summary of Nef-specific CD8+ T-cell responses, infection outcome, and extent of sequence variation in the Nef RL10 epitope
| Group | Animal ID | % tetramer+ CD8+ T cells on DOCa | % Nef ORF-reactive CD8+ T cells at wk 2 post-rAd5b | VL |
% of WT Nef RL10 reads |
||
|---|---|---|---|---|---|---|---|
| Peakc | Set pointd | Wk 2.4 p.i.e | Wk 6 p.i.f | ||||
| 1 | r01068 | 1.31 | 0.09 | 1.4 × 106 | 3.7 × 103 | 96.3 | 95 |
| r04001 | 17 | 1.75 | 1.2 × 106 | 2.3 × 105 | 11.7 | 0 | |
| r06008 | 0.87 | 2.82 | 4.5 × 105 | 4.0 × 101 | 100 | 16 | |
| r08017 | 0.63 | 2.15 | 4.4 × 106 | 7.0 × 103 | 100 | 100 | |
| r08018 | 6.33 | 1.53 | 9.4 × 105 | 1.6 × 102 | 99.7 | 7.9 | |
| r08020 | 1.3 | 0.81 | 2.4 × 107 | 9.7 × 102 | 96.3 | 24.3 | |
| r09029 | 0.63 | 2.19 | 9.0 × 104 | 1.7 × 103 | 96.6 | 82.8 | |
| r09089 | 0.58 | 0.4 | 4.5 × 106 | 4.4 × 101 | 100 | 98 | |
| 2 | rh2099 | NA | 48.4 | 3.0 × 107 | 1.6 × 106 | 100 | 80 |
| r97076 | NA | 0.01 | 7.4 × 105 | 9.1 × 103 | 99.8 | 96.8 | |
| r08016 | NA | 0.54 | 4.2 × 107 | 3.2 × 103 | 100 | 69.3 | |
| r08032 | NA | 0.07 | 3.0 × 106 | 7.7 × 102 | 100 | 1.7 | |
| r08054 | NA | 1.25 | 8.6 × 105 | 7.0 × 101 | 100 | 100 | |
| r09014 | NA | 8.41 | 1.2 × 106 | 7.0 × 103 | 100 | 97.1 | |
| r09037 | NA | 0.03 | 1.1 × 107 | 1.1 × 102 | 100 | 61.2 | |
| r09068 | NA | 0.32 | 1.0 × 107 | 4.1 × 104 | 100 | 47.8 | |
| 3 | r04087 | NA | NA | 7.8 × 106 | 4.6 × 105 | 100 | ND |
| r09092 | NA | NA | 9.6 × 106 | 3.9 × 103 | 100 | ND | |
Tetramer staining performed in PBMC on the day of the 1st SIV challenge (DOC). The graphical representation of these data is shown in Fig. 2A. NA, not applicable.
The percentages refer to the frequency of vaccine-induced CD8+ T cells responding to stimulation by the Nef ORF pool in an ICS assay performed at week 2 post-rAd5 boost. The graphical representation of these data is shown in Fig. 3A.
Highest VL measured within the first 4 weeks of infection. The values correspond to vRNA copies/ml of plasma. The graphical representation of these data is shown in Fig. 6D.
Set point VLs were determined as the geometric mean of VLs measured between week 10 p.i. and the last time point available for each animal. The values correspond to vRNA copies/ml of plasma. The graphical representation of these data is shown in Fig. 6E.
The graphical representation of these data is shown in Fig. 8.
The graphical representation of these data is shown in Fig. 7.